Inhibition of leptin and leptin receptor gene expression by silibinin-curcumin combination

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 11, 2013, Pages 6595-6599

  Nejati Koshki, Kazem ^a   Akbarzadeh, Abolfazl ^a   Pourhasan Moghaddam, Mohammad ^a   Abhari, Alireza ^b   Dariushnejad, Hassan ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Curcumin; Leptin; Silibinin; T47D cell line

Indexed keywords

EID: 84892453411     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.11.6595     Document Type: Article

References (35)

1. Boominathan, Lakshmanane (2009). Curcumin Functions as a Positive Regulator of miRNA Processing & a Negative Regulator of Cancer Stem Cell Proliferation.
2. Chiu TL, Su CC (2009). Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells. Int J Mol Med, 23, 469-75.
3. Cottrell EC, Mercer JG (2012). Leptin receptors. Handb Exp Pharmacol, 3-21.
4. De Kok TM, van Breda SG, Manson MM (2008). Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr, 47, 51-9.
5. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V, et al (2002). Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 293, 622-8.
6. Fazeli M, Zarkesh-Esfahani H, Wu Z, et al (2006). Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J Immunol Methods, 312, 190-200.
7. Fusco R, Galgani M, Procaccini C, et al (2010). Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting. Endocr Relat Cancer, 17, 373-82.
8. García-Robles MJ, Segura-Ortega JE, Fafutis-Morris M (2013). The biology of leptin and its implications in breast cancer: a general view. J Interferon Cytokine Res, [Epub ahead of print].
9. Go O, Freeman RH, Reams GP, et al (2013). Obesity hypertension: pathophysiological role of leptin in neuroendocrine dysregulation. Am J Med Sci, [Epub ahead of print]
10. Gonzalez RR, Watters A, Xu Y, et al (2009). Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res, 11, 36.
11. Hardwick JC, Van Den Brink GR, Offerhaus GJ, et al (2001). Leptin is a growth factor for colonic epithelial cells. Gastroenterology, 121, 79-90.
12. Hu X, Juneja SC, Maihle NJ, et al (2002). Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst, 94, 1704-11.
13. Ishikawa M, Kitayama J, Nagawa H (2004). Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res, 10, 4325-31.
14. Kaur M, Agarwal R (2007). Silymarin and epithelial cancer chemoprevention: how close we are to bedside. Toxicol Appl Pharmacol, 224, 350-9.
15. Kelesidis T, Kelesidis I, Chou S, et al (2010). Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med, 152, 93-100.
16. Koda M, Sulkowska M, Kanczuga-Koda L, et al (2007). Expression of leptin and its receptor in female breast cancer in relation with selected apoptotic markers. Folia Histochem Cytobiol, 45, 187-91.
17. Laud K, Gourdou I, Pessemesse L, et al (2002). Identification of leptin receptors in human breast cancer: Functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol, 188, 219-26.
18. Lin CJ, Sukarieh R, Pelletier J (2009). Silibinin inhibits translation initiation: implications for anticancer therapy. Mol Cancer Ther, 8, 1606-12.
19. Liu Z, Uesaka T, Watanabe H, et al (2001). High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol, 19, 1009-14.
20. Löffler S, Aust G, Köhler U, et al (2001). Evidence of leptin expression in normal and polycystic human ovaries. Mol Hum Reprod, 7, 1143-9.
21. Maymó JL, Pérez AP, Gambino Y, et al (2011). Leptin gene expression in the placenta--regulation of a key hormone in trophoblast proliferation and survival. Placenta, 2, 146-53.
22. Mix H, Widjaja A, Jandl O (2000). Expression of leptin and leptin receptor isoforms in the human stomach. Gut, 47, 481-6.
23. Morroni M, De Matteis R, Palumbo C, et al (2004). In vivo leptin expression in cartilage and bone cells of growing rats and adult humans. J Anat, 205, 291-6.
24. Nejati-Koshki K, Zarghami N, Pourhassan-Moghaddam M, et al (2012). Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors. Cytotechnology, 64, 719-26.
25. Oda A, Taniguchi T, Yokoyama M (2001). Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci, 47, 141-50.
26. Peters JH, Simasko SM, Ritter RC (2007). Leptin analog antagonizes leptin effects on food intake and body weight but mimics leptin-induced vagal afferent activation. Endocrinology, 148, 2878-85.
27. Ray A, Cleary MP (2010). Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin Ther Targets, 14, 443-51.
28. Sareen R, Jain N, Pandit V (2013). Curcumin: A boon to Colonic Diseases. Curr Drug Targets, 14. [Epub ahead of print]
29. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics 2012. CA Cancer J Clin, 62, 10-29.
30. Singh RP, Sharma G, Dhanalakshmi S, et al (2009). Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Mol Cancer Ther, 8, 1606-12.
31. Solberg R, Aas V, Thoresen GH, et al (2005). Leptin expression in human primary skeletal muscle cells is reduced during differentiation. J Cell Biochem, 96, 89-96.
32. Soyupek S, Armagan A, Serel TA, et al (2005). Leptin expression in the testicular tissue of fertile and infertile men. Arch Androl, 51, 239-46.
33. Wazir U, Al Sarakbi W, Jiang WG, et al (2012). Evidence of an autocrine role for leptin and leptin receptor in human breast cancer. Cancer Genomics Proteomics, 9, 383-7.
34. Yi KW, Shin JH, Seo HS, et al (2008). Role of estrogen receptoralpha and -beta in regulating leptin expression in 3T3-L1 adipocytes. Obesity (Silver Spring), 16, 2393-9.
35. Yom CK, Lee KM, Han W, et al (2013). Leptin as a potential target for estrogen receptor-positive breast cancer. J Breast Cancer, 16, 138-45.